Fundraising FoxBioGeneration Ventures — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach.
BiotechDeep TechHealthtech
Tjeerd Barf(Co-founder & CEO)inArwin Ridder(Co-founder & COO)inAd IJzerman(Co-founder & SAB Chair)inJason(Chief Scientific Officer)in
Co-investorsThuja CapitalSeroba Life SciencesBGV
Essenvia offers a regulatory information management platform for medical device regulatory affairs teams, automating submissions (including FDA eSTAR), centralizing registrations, and providing AI-driven regulatory intelligence and lifecycle tracking.
AI & Machine LearningMedical DevicesSaaSWoodland Hills, US
Basant Sahoo(Co-founder & CTO)inSoumya Mahapatra(Co-founder & CEO)in
Co-investorsArka Venture LabsCore91.vcExpert DOJORebright PartnersBenhamou Global VenturesWavemaker Three-Sixty Health
Tessellate Bio is a biotech company researching synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD) to build a pipeline of first-in-class precision medicines.
BiotechHealthtech
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Stack Identity
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.